Peter A. McCullough, MD, MPH, Christopher T. Chan, MD, Eric D

Slides:

Advertisements

Similar presentations

Copland M, Komenda P, Weinhandl ED, McCullough PA, Morfin JA

Advertisements

McCullough PA, Chan CT, Weinhandl ED, Burkart JM, Bakris GL

McCullough PA, Chan CT, Weinhandl ED, Burkart JM, Bakris GL

Copland M, Komenda P, Weinhandl ED, McCullough PA, Morfin JA

Intensive Hemodialysis and Health-related Quality of Life

Intensive Hemodialysis and Health-related Quality of Life

Intensive Hemodialysis and Potential Risks with Increasing Treatment

Hemodialysis Vascular Access Creation in Patients Switching From Peritoneal Dialysis to Hemodialysis: A Population-Based Retrospective Cohort Ahmed A.

Bakris GL, Burkhart JM, Weinhandl ED, McCullough PA, Kraus MA

Bakris GL, Burkhart JM, Weinhandl ED, McCullough PA, Kraus MA

Comparison of the CKD Epidemiology Collaboration (CKD-EPI) and Modification of Diet in Renal Disease (MDRD) Study Equations: Prevalence of and Risk Factors.

Peritoneal dialysis American Journal of Kidney Diseases

Gregory L. Hundemer, MD, MPH, Andrew Z. Fenves, MD, Kristy M

Regional Differences in the Associations Between Prescribed Dialysate Sodium Concentration and Interdialytic Weight Gain in the Dialysis Outcomes and.

Development of Reduced Kidney Function in Rheumatoid Arthritis

Effects of a Nationwide Predialysis Educational Program on Modality Choice, Vascular Access, and Patient Outcomes Eduardo Lacson, MD, MPH, Weiling Wang,

Francesca Mallamaci, MD, Giovanni Tripepi, PhD

Dorian Schatell, MS, Meg Wise, PhD, Kristi Klicko, CHES, Bryan N

Surviving the First Year of Peritoneal Dialysis: Enduring Hard Times

Comparison of the CKD Epidemiology Collaboration (CKD-EPI) and Modification of Diet in Renal Disease (MDRD) Study Equations: Risk Factors for and Complications.

Sustainable Community-Based CKD Screening Methods Employed by the National Kidney Foundation's Kidney Early Evaluation Program (KEEP) Peter A. McCullough,

Intensive Hemodialysis and Potential Risks with Increasing Treatment

Intensive Hemodialysis and Health-Related Quality of Life

The risk of hospitalization and modality failure with home dialysis

Dialysis Facility Ownership and Epoetin Dosing in Hemodialysis Patients: A Dialysis Provider’s Perspective J. Michael Lazarus, MD, Raymond M. Hakim,

Solute-Solver: A Web-Based Tool for Modeling Urea Kinetics for a Broad Range of Hemodialysis Schedules in Multiple Patients John T. Daugirdas, MD, Thomas.

Three Versus 4 Daily Exchanges and Residual Kidney Function Decline in Incident CAPD Patients: A Randomized Controlled Trial Hao Yan, MD, Wei Fang, MD,

Hemodialysis Facility Variation in Hospitalization and Transfusions Using Medicare Claims: The DOPPS Practice Monitor for US Dialysis Care Douglas S.

Daniel E. Weiner, MD, MS American Journal of Kidney Diseases

Wayne Trebbin, MD, Peter Monteleone, MD

Salt and Hypertension American Journal of Kidney Diseases

Ioannis Koulouridis, MD, MS, Lori Lyn Price, MAS, Nicolaos E

Volume 80, Issue 10, Pages (November 2011)

Anemia management for hemodialysis patients: Kidney Disease Outcomes Quality Initiative (K/DOQI) guidelines and Dialysis Outcomes and Practice Patterns.

Hemoglobin Level and Transfusions in Patients on Maintenance Dialysis: Where the Rubber Meets the Road Eduardo Lacson, MD, MPH, Franklin Maddux, MD

Effect of Intensive Insulin Therapy and Pentastarch Resuscitation on Acute Kidney Injury in Severe Sepsis George Thomas, MD, MPH, Ethan M. Balk, MD,

David C. Mendelssohn, MD, FRCPC, Jay B. Wish, MD

On Statin Treatment to Prevent Sepsis in Dialysis Patients

Michael Copland, MD, Paul Komenda, MD, Eric D

Factors Influencing Route of Administration for Epoetin Treatment Among Hemodialysis Patients in the United States Mae Thamer, PhD, Yi Zhang, DDS, MS,

Mortality, Hospitalization, and Technique Failure in Daily Home Hemodialysis and Matched Peritoneal Dialysis Patients: A Matched Cohort Study Eric D.

A Decade After the KDOQI CKD Guidelines: A Perspective From Mexico

Plasma Parathyroid Hormone Level and Prevalent Cardiovascular Disease in CKD Stages 3 and 4: An Analysis From the Kidney Early Evaluation Program (KEEP)

Beef Tea, Vitality, Creatinine, and the Estimated GFR

Jeffrey Perl, MD, FRCP(C), Christopher T. Chan, MD, FRCP(C)

Quiz Page April 2008 American Journal of Kidney Diseases

Study Designs in Patient-Oriented Research

Manish M. Tanna, MD, Edward F. Vonesh, PhD, Stephen M. Korbet, MD

The Precision of Standardized Hospitalization, Readmission, and Mortality Ratios for Dialysis Facilities Steven M. Brunelli, MD, MSCE, Adam G. Walker,

Intensive Hemodialysis and Potential Risks With Increasing Treatment

Daniel E. Weiner, MD, MS, Mark J. Sarnak, MD, MS

George L. Bakris, MD, John M. Burkart, MD, Eric D

Racial Differences in Kidney Function Among Individuals With Obesity and Metabolic Syndrome: Results From the Kidney Early Evaluation Program (KEEP)

KDOQI Clinical Practice Guideline and Clinical Practice Recommendations for Anemia in Chronic Kidney Disease: 2007 Update of Hemoglobin Target American.

Risk for Incident Renal Dialysis in a Managed Care Population

Trial Quality in Nephrology: How Are We Measuring Up?

Removal of Dabigatran by Hemodialysis

Multidrug-Resistant Organisms Within the Dialysis Population: A Potentially Preventable Perfect Storm David P. Calfee, MD, MS American Journal of Kidney.

National Kidney Foundation's Kidney Early Evaluation Program (KEEP) Annual Data Report 2011: Executive Summary Adam T. Whaley-Connell, DO, MSPH, Joseph.

Kidney Failure Treatment: The Freedom to Choose

Hypertension and CKD: Kidney Early Evaluation Program (KEEP) and National Health and Nutrition Examination Survey (NHANES), Madhav V. Rao,

The Use of Vaccines in Adult Patients With Renal Disease

Achieving Fairness in Access to Kidney Transplant: A Work in Progress

American Journal of Kidney Diseases

Quiz Page June 2011 American Journal of Kidney Diseases

Dialysis Research and N-of-1 Trials: Made for Each Other?

Clinical Practice Recommendations For Peritoneal Dialysis Adequacy

National Kidney Foundation's Kidney Early Evaluation Program (KEEP) Annual Data Report 2009: Executive Summary Peter A. McCullough, MD, MPH, Joseph A.

Maristela Böhlke, PhD American Journal of Kidney Diseases

Clinical Practice Guidelines for Peritoneal Dialysis Adequacy

Presentation transcript:

Intensive Hemodialysis, Left Ventricular Hypertrophy, and Cardiovascular Disease Peter A. McCullough, MD, MPH, Christopher T. Chan, MD, Eric D. Weinhandl, PhD, MS, John M. Burkart, MD, George L. Bakris, MD American Journal of Kidney Diseases Volume 68, Issue 5, Pages S5-S14 (November 2016) DOI: 10.1053/j.ajkd.2016.05.025 Copyright © 2016 National Kidney Foundation, Inc. Terms and Conditions

Figure 1 Rates of death and cardiovascular hospitalization on the day after the 2-day gap in dialysis treatment and on all other days.4 American Journal of Kidney Diseases 2016 68, S5-S14DOI: (10.1053/j.ajkd.2016.05.025) Copyright © 2016 National Kidney Foundation, Inc. Terms and Conditions

Figure 2 Distribution of primary cause of death in hemodialysis patients, 2011 to 2013.2 American Journal of Kidney Diseases 2016 68, S5-S14DOI: (10.1053/j.ajkd.2016.05.025) Copyright © 2016 National Kidney Foundation, Inc. Terms and Conditions

Figure 3 Effects of intensive versus conventional hemodialysis on left ventricular mass in the Frequent Hemodialysis Network (FHN) Daily Trial,37 FHN Nocturnal Trial,38 and Canadian trial of nocturnal hemodialysis.39 Estimated treatment effects (solid dots) and associated 95% confidence intervals (solid lines) are displayed at the bottom. American Journal of Kidney Diseases 2016 68, S5-S14DOI: (10.1053/j.ajkd.2016.05.025) Copyright © 2016 National Kidney Foundation, Inc. Terms and Conditions

Figure 4 Relative hazards of cause-specific cardiovascular hospitalization for short daily hemodialysis (SDHD) versus in-center hemodialysis (CIHD)45 and versus peritoneal dialysis (PD).47 Solid lines represent 95% confidence intervals around estimated hazard ratios (solid dots). American Journal of Kidney Diseases 2016 68, S5-S14DOI: (10.1053/j.ajkd.2016.05.025) Copyright © 2016 National Kidney Foundation, Inc. Terms and Conditions